Inhibitor of apoptosis-stimulating protein of p53 (iASPP) is required for neuronal survival after axonal injury

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Wilson, Ariel M ^a   Chiodo, Vince A ^b   Boye, Sanford L ^b   Brecha, Nicholas C ^c   Hauswirth, William W ^b   Polo, Adriana Di ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; INHIBITOR OF APOPTOSIS STIMULATING PROTEIN OF P53; MEMBRANE PROTEIN; PARVOVIRUS VECTOR; PUMA PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; REPRESSOR PROTEIN; SIGNAL PEPTIDE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AXONAL INJURY; BINDING AFFINITY; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; GENE SILENCING; IN VIVO STUDY; NERVE FIBER TRANSECTION; NONHUMAN; OPTIC NERVE; OPTIC NERVE LESION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; RETINA GANGLION CELL; ANIMAL; GENETICS; METABOLISM; NERVE CELL; NERVE FIBER; OPTIC NERVE INJURY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; AXONS; AXOTOMY; CELL SURVIVAL; FEMALE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEURONS; OPTIC NERVE; OPTIC NERVE INJURIES; RATS; RATS, SPRAGUE-DAWLEY; REPRESSOR PROTEINS; RNA, SMALL INTERFERING;

EID: 84899442060     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094175     Document Type: Article

References (63)

1. Bergamaschi D, Samuels Y, O'Neil NJ, Trigiante G, Crook T, et al. (2003) iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet 33: 162-167. (Pubitemid 36177067)
2. Yang JP, Hori M, Sanda T, Okamoto T (1999) Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor. J Biol Chem 274: 15662-15670.
3. Slee E, Gillotin Sb, Bergamaschi D, Royer C, Llanos S, et al. (2004) The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization. Oncogene 23: 9007-9016.
4. Ao Y, Rohde LH, Naumovski L (2001) p53-interacting protein 53BP2 inhibits clonogenic survival and sensitizes cells to doxorubicin but not paclitaxel-induced apoptosis. Oncogene 20: 2720-2725. (Pubitemid 32525303)
5. Bergamaschi D, Samuels Y, Sullivan A, Zvelebil M, Breyssens H, et al. (2006) iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet 38: 1133-1141. (Pubitemid 44470358)
6. Samuels Lev Y, O'Connor D, Bergamaschi D, Trigiante G, Hsieh J, et al. (2001) ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 8: 781-794. (Pubitemid 33030212)
7. Lopez CD, Ao Y, Rohde LH, Perez TD, O'Connor DJ, et al. (2000) Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53. Mol Cell Biol 20: 8018-8025.
8. Ahn J, Byeon I-J, Byeon C-H, Gronenborn A (2009) Insight into the structural basis of pro- and antiapoptotic p53 modulation by ASPP proteins. J Biol Chem 284: 13812-13822.
9. Bergamaschi D, Samuels Y, Jin B, Duraisingham S, Crook T, et al. (2004) ASPP1 and ASPP2: common activators of p53 family members. Mol Cell Biol 24: 1341-1350. (Pubitemid 38112194)
10. Bergamaschi D, Samuels Y, O'Neil N, Trigiante G, Crook T, et al. (2003) iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet 33: 162-167. (Pubitemid 36177067)
11. Yang J, Hori M, Sanda T, Okamoto T (1999) Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor. J Biol Chem 274: 15662-15670.
12. Zhang X, Wang M, Zhou C, Chen S, Wang J (2005) The expression of iASPP in acute leukemias. Leukemia Res 29: 179-183. (Pubitemid 39647513)
13. Li G, Wang R, Gao J, Deng K, Wei J, et al. (2011) RNA interference-mediated silencing of iASPP induces cell proliferation inhibition and G0/G1 cell cycle arrest in U251 human glioblastoma cells. Mol Cell Biochem 350: 193-200.
14. Jiang L, Siu MKY, Tam K-F, Lu X, Lam EWF, et al. (2011) iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe. Clin Cancer Res 17: 6924-6933.
15. Liu Z, Huang D, Liu Y, Zhang X, Liu L, et al. (2012) Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance. Med Oncol 29: 3381-3388.
16. Berkelaar M, Clarke DB, Wang Y-C, Bray GM, Aguayo AJ (1994) Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci 14: 4368-4374. (Pubitemid 24200558)
17. Cheng L, Sapieha P, Kittlerová P, Hauswirth WW, Di Polo A (2002) TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J Neurosci 22: 3977-3986. (Pubitemid 37465706)
18. Wilson A, Morquette B, Abdouh M, Unsain Ns, Barker P, et al. (2013) ASPP1/2 regulate p53-dependent death of retinal ganglion cells through PUMA and Fas/CD95 activation in vivo. J Neurosci 33: 2205-2216.
19. Pernet V, Hauswirth WW, Di Polo A (2005) Extracellular signal-regulated kinase 1/2 mediates survival, but not axon regeneration, of adult injured central nervous system neurons in vivo. J Neurochem 93: 72-83. (Pubitemid 40463517)
20. Hamar P, Song E, Kokeny G, Chen A, Ouyang N, et al. (2004) Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc Natl Acad Sci U S A 101: 14883-14888. (Pubitemid 39410769)
21. Zhong L, Li B, Mah C, Govindasamy L, Agbandje McKenna M, et al. (2008) Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc Nat Acad Sci USA 105: 7827-7832. (Pubitemid 351872723)
22. Hauswirth WW, Lewin AS, Zolotukhin S, Muzyczka N (2000) Production and purification of recombinant adeno-associated virus. Methods Enzymol 316: 743-761. (Pubitemid 30235704)
23. Leon S, Yin Y, Nguyen J, Irwin N, Benowitz LI (2000) Lens injury stimulates axon regeneration in the mature rat optic nerve. J Neurosci 20: 4615-4626. (Pubitemid 30396627)
24. Mansour-Robaey S, Clarke DB, Wang Y-C, Bray GM, Aguayo AJ (1994) Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci USA 91: 1632-1636. (Pubitemid 24080259)
25. Lebrun-Julien F, Morquette B, Douillette A, Saragovi HU, Di Polo A (2009) Inhibition of p75NTR in glia potentiates TrkA-mediated survival of injured retinal ganglion cells. Mol Cell Neurosci 40: 410-420.
26. Rodriguez A, de Sevilla Muller LP, Brecha N (2013) The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina. J Comp Neurol (In Press).
27. Nadal-Nicolas F, Jimenez-Lopez M, Sobrado Calvo P, Nieto-Lopez L, Canovas-Martinez I, et al. (2009) Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Invest Ophthalmol Vis Sci 50: 3860-3868.
28. Perry VH (1981) Evidence for an amacrine cell system in the ganglion cell layer of the rat retina. Neurosci 6: 931-944.
29. Schlamp C, Montgomery A, Mac Nair C, Schuart C, Willmer D, et al. (2013) Evaluation of the percentage of ganglion cells in the ganglion cell layer of the rodent retina. Mol Vis 19: 1387-1396.
30. Kwong JMK, Caprioli J, Piri N (2010) RNA binding protein with multiple splicing: a new marker for retinal ganglion cells. Invest Ophthalmol Vis Sci 51: 1052-1058.
31. Villegas-Perez MP, Vidal-Sanz M, Rasminsky M, Bray GM, Aguayo AJ (1993) Rapid and protracted phases of retinal ganglion cell loss follow axotomy in the optic nerve of adult rats. J Neurobiol 24: 23-36. (Pubitemid 23001493)
32. Nadal-Nicolas F, Jimenez Lopez M, Salinas Navarro M, Sobrado Calvo P, Alburquerque Bejar J, et al. (2012) Whole number, distribution and co-expression of brn3 transcription factors in retinal ganglion cells of adult albino and pigmented rats. PLOS ONE 7: e49830-e49830.
33. Agudo Barriuso M, Lahoz A, Nadal-Nicolas F, Sobrado Calvo P, Piquer Gil M, et al. (2013) Metabolomic changes in the rat retina after optic nerve crush. Invest Ophthalmol Vis Sci 54: 4249-4259.
34. Lu M, Breyssens H, Salter V, Zhong S, Hu Y, et al. (2013) Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP. Cancer Cell 23: 618-633.
35. Wilson AM, Di Polo A (2012) Gene therapy for retinal ganglion cell neuroprotection in glaucoma. Gene Ther 19: 127-136.
36. Pernet V, Di Polo A (2006) Synergistic action of brain-derived neurotrophic factor and lens injury promotes retinal ganglion cell survival, but leads to optic nerve dystrophy in vivo. Brain 129: 1014-1026.
37. Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, et al. (1999) p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 19: 1202-1209. (Pubitemid 29046862)
38. Knights C, Catania J, Di Giovanni S, Muratoglu S, Perez R, et al. (2006) Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J Cell Biol 173: 533-544. (Pubitemid 43765200)
39. Yamaguchi H, Woods N, Piluso L, Lee H-H, Chen J, et al. (2009) p53 acetylation is crucial for its transcription-independent proapoptotic functions. J Biol Chem 284: 11171-11183.
40. Dumaz N, Meek DW (1999) Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J 18: 7002-7010. (Pubitemid 30000453)
41. Unger T, Sionov RV, Moallem E, Yee CL, Howley PM, et al. (1999) Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene 18: 3205-3212. (Pubitemid 29286965)
42. Gabriel R, Witkovsky P (1998) Cholinergic, but not the rod pathway-related glycinergic (All), amacrine cells contain calretinin in the rat retina. Neurosci Lett 247: 179-182. (Pubitemid 28240126)
43. Xu X, Fang Y, Lee T, Forrest D, Gregory Evans C, et al. (2009) Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling. Cell 137: 1018-1031.
44. Guo Y, Pajovic S, Gallie B (2008) Expression of p14ARF, MDM2, and MDM4 in human retinoblastoma. Biochem Biophys Res Commun 375: 1-5.
45. Liu Z-J, Cai Y, Hou L, Gao X, Xin H-M, et al. (2008) Effect of RNA interference of iASPP on the apoptosis in MCF-7 breast cancer cells. Cancer Invest 26: 878-882.
46. Zhang B, Xiao HJ, Chen J, Tao X, Cai LH (2011) Inhibitory member of the apoptosis-stimulating protein of p53 (ASPP) family promotes growth and tumorigenesis in human p53-deficient prostate cancer cells. Prostate Cancer Prostatic Dis 14: 219-224.
47. Li S, Shi G, Yuan H, Zhou T, Zhang Q, et al. (2012) Abnormal expression pattern of the ASPP family of proteins in human non-small cell lung cancer and regulatory functions on apoptosis through p53 by iASPP. Oncol Rep 28: 133-140.
48. Liu H, Wang M, Diao S, Rao Q, Zhang X, et al. (2009) siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53. Leukemia Res 33: 1243-1248.
49. Hornbeck P, Kornhauser J, Tkachev S, Zhang B, Skrzypek E, et al. (2012) PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res 40: D261-D270.
50. Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, et al. (1999) Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene 18: 2892-2900. (Pubitemid 29250879)
51. Levkovitch-Verbin H, Dardik R, Vander S, Nisgav Y, Kalev-Landoy M, et al. (2006) Experimental Glaucoma and Optic Nerve Transection Induce Simultaneous Upregulation of Proapoptotic and Prosurvival Genes. Invest Ophthalmol Vis Sci 47: 2491-2497. (Pubitemid 351639832)
52. Jin S, Mazzacurati L, Zhu X, Tong T, Song Y, et al. (2003) Gadd45a contributes to p53 stabilization in response to DNA damage. Oncogene 22: 8536-8540. (Pubitemid 37523906)
53. Lambert PF, Kashanchi F, Radonovich MF, Shiekhattar R, Brady JN (1998) Phosphorylation of p53 serine 15 increases interaction with CBP. J Biol Chem 273: 33048-33053. (Pubitemid 28557701)
54. Gaub P, Joshi Y, Wuttke A, Naumann U, Schnichels S, et al. (2011) The histone acetyltransferase p300 promotes intrinsic axonal regeneration. Brain 134: 2134-2148.
55. Krummel K, Lee C, Toledo F, Wahl G (2005) The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation. Proc Nat Acad Sci USA 102: 10188-10193. (Pubitemid 41023347)
56. Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, et al. (2003) Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4: 321-328. (Pubitemid 37329796)
57. Kim H, Tu H-C, Ren D, Takeuchi O, Jeffers J, et al. (2009) Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol Cell 36: 487-499.
58. Ren D, Tu H-C, Kim H, Wang G, Bean G, et al. (2010) BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science 330: 1390-1393.
59. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, et al. (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16: 2794-2804. (Pubitemid 27226216)
60. Kim HS, Park CK (2005) Retinal ganglion cell death is delayed by activation of retinal intrinsic cell survival program. Brain Res 1057: 17-28. (Pubitemid 41338083)
61. Wax MB, Tezel G, Yang J, Peng G, Patil RV, et al. (2008) Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived Fas-ligand. J Neurosci 28: 12085-12096.
62. Ju KR, Kim HS, Kim JH, Lee NY, Park CK (2006) Retinal glial cell responses and Fas/FasL activation in rats with chronic ocular hypertension. Brain Res 1122: 209-221. (Pubitemid 44708124)
63. Gregory M, Hackett C, Abernathy E, Lee K, Saff R, et al. (2011) Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death. PLOS ONE 6: e17659-e17659.